{"gene":"HS6ST1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2018,"finding":"A missense mutation in HS6ST1 identified in a familial delayed puberty pedigree reduces heparan sulfate 6-O-sulfotransferase enzymatic activity in vitro, and heterozygous Hs6st1 loss in mice causes delayed vaginal opening (a proxy for delayed puberty) without affecting GnRH neuron counts.","method":"In vitro sulfotransferase activity assay of mutant protein; Hs6st1+/- mouse phenotyping (vaginal opening timing, GnRH neuron immunostaining)","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro enzymatic assay of mutant plus in vivo mouse loss-of-function with defined phenotypic readout","pmids":["29931354"],"is_preprint":false},{"year":2014,"finding":"Hs6st1 loss-of-function in mice causes corpus callosum agenesis associated with precocious accumulation of Sox9+ glial cells at the indusium griseum, hyperactivation of ERK signaling (~6-fold) in the telencephalic midline, and elevated Fgf8 protein levels (~2-fold); genetic or pharmacological suppression of the Fgf8/ERK axis rescues both the glial and axonal CC phenotypes, placing Hs6st1 upstream of Fgf8/ERK in corpus callosum development.","method":"Hs6st1-/- mouse genetics, immunohistochemistry for Sox9 and pERK, Western blotting for Fgf8, genetic rescue (Fgf8 hypomorph crosses), pharmacological ERK inhibition","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, multiple orthogonal methods, genetic and pharmacological epistasis rescue","pmids":["24501377"],"is_preprint":false},{"year":2017,"finding":"In ex vivo mouse neural tissue lacking Hs6st1, exogenous Fgf8 protein gradient formation is delayed and the steady-state Fgf8 protein levels in the gradient are significantly elevated compared to wild type; additionally, Hs6st1-deficient tissue shows enhanced ERK signaling in response to Fgf8, demonstrating that Hs6st1 normally acts as an agonist of Fgf8-induced ERK signaling and stabilizes Fgf8 concentration gradients.","method":"Ex vivo living neural tissue cultures from Hs6st1-/- embryos challenged with exogenous Fgf8; immunofluorescence for Fgf8 protein gradient and pERK; heparanase enzymatic removal controls","journal":"Biology open","confidence":"High","confidence_rationale":"Tier 2 — direct ex vivo assay in KO tissue with multiple orthogonal readouts (gradient imaging, ERK signaling), physiological relevance confirmed in vivo","pmids":["29158323"],"is_preprint":false},{"year":2012,"finding":"Hs6st1 is expressed at the tips of elongating prostatic epithelial buds (where Sulf1 is excluded), creating a zone of high HS 6-O sulfation at bud tips that supports FGF10-mediated ERK1/2 signaling; this spatial regulation opposes the Sulf1-mediated reduction of 6-O sulfation in peri-mesenchymal epithelium that is induced by BMP signaling.","method":"In situ hybridization for Hs6st1/Sulf1 expression, immunohistochemistry for 6-O sulfated HS, exogenous BMP4/BMP7 treatment with ERK1/2 readout in urogenital sinus explants","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2–3 — expression-based localization plus functional IHC and BMP treatment assay; single lab, moderate mechanistic depth","pmids":["23074159"],"is_preprint":false},{"year":2023,"finding":"In Xenopus, Hs6st1 is expressed in the lateral sensorial layer of neuroectoderm and its activity causes cell-autonomous retention of Fgf8a on Hs6st1-expressing cells while promoting dispersal of the BMP antagonist Noggin away from those cells; Hs6st1 overexpression expands the neural plate (Sox3+) domain, and CRISPR/Cas9 knockout expands the neural plate and causes retinal malformation, demonstrating that Hs6st1-mediated 6-O sulfation differentially regulates morphogen distributions to pattern the neuroectoderm.","method":"In situ hybridization, Hs6st1 mRNA overexpression, CRISPR/Cas9 knockout in Xenopus, immunostaining for Fgf8a and Noggin distribution","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with morphogen localization readouts in Xenopus ortholog; single lab","pmids":["36739958"],"is_preprint":false},{"year":2022,"finding":"Disruption of Hs6st1 in mouse neuronal cells (and parallel disruption of Fgfr1) alters transcriptome in convergent biological processes: upregulation of extracellular pathway genes and downregulation of chromatin pathway genes; bioinformatics analysis indicates Hs6st1 and Fgfr1 regulate gene transcription via the transcription factors Sox9/Sox10 and chromatin regulator Chd7.","method":"RNA sequencing of Hs6st1-disrupted mouse neuronal cells, machine learning-based mutation effect prediction, genomics/bioinformatics pathway analysis","journal":"Human molecular genetics","confidence":"Low","confidence_rationale":"Tier 3–4 — transcriptomics and bioinformatics without direct protein-level mechanistic validation","pmids":["35899427"],"is_preprint":false},{"year":2026,"finding":"HS6ST1 depletion in AML cells increases sensitivity to cytarabine and reduces TGF-β1-mediated pro-survival signaling, demonstrating that HS6ST1 promotes chemotherapy resistance by supporting TGF-β1 signaling; HS2ST1 depletion (but not HS6ST1 depletion) increases bone marrow leukemic burden in cell-line-derived xenografts.","method":"shRNA/CRISPR depletion of HS6ST1 in AML cell lines, cytarabine sensitivity assays, TGF-β1 signaling readouts, cell-line-derived xenograft models, surfen (HS antagonist) combination treatment","journal":"Research square","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined signaling pathway (TGF-β1) and phenotypic readout (drug resistance), in vitro and in vivo; single lab, preprint","pmids":["41727567"],"is_preprint":true}],"current_model":"HS6ST1 is a heparan sulfate 6-O-sulfotransferase that catalyzes sulfation of heparan sulfate chains to modulate extracellular morphogen (particularly FGF8) gradients and downstream ERK signaling, thereby regulating brain midline/corpus callosum development, puberty onset via GnRH neuron function, neuroectodermal patterning, and AML chemotherapy resistance through TGF-β1 pathway support."},"narrative":{"teleology":[{"year":2012,"claim":"HS6ST1 was shown to create spatially restricted zones of high 6-O-sulfation at prostatic epithelial bud tips that support FGF10/ERK signaling, establishing that its sulfotransferase activity has localized signaling consequences in developing tissues.","evidence":"In situ hybridization, immunohistochemistry for 6-O-sulfated HS, and BMP treatment of urogenital sinus explants in mouse","pmids":["23074159"],"confidence":"Medium","gaps":["Functional consequence of Hs6st1 loss in prostate branching not tested by knockout","Relationship between 6-O-sulfation and FGF10 binding affinity not biochemically resolved"]},{"year":2014,"claim":"Hs6st1 knockout in mice revealed that 6-O-sulfation acts upstream of FGF8/ERK signaling in corpus callosum formation, with loss causing glial fate precocity and axon guidance failure—both rescued by reducing FGF8 or ERK activity.","evidence":"Hs6st1−/− mouse analysis with immunohistochemistry, Western blotting, genetic crosses to Fgf8 hypomorphs, and pharmacological ERK inhibition","pmids":["24501377"],"confidence":"High","gaps":["Whether HS6ST1 directly modifies HS chains that bind FGF8 or acts through intermediate proteoglycans is unresolved","Cell-type-specific contributions (glia vs. neurons) not dissected with conditional knockouts"]},{"year":2017,"claim":"Ex vivo gradient assays demonstrated that Hs6st1 directly shapes extracellular FGF8 protein gradients and normally restrains ERK hyperactivation, resolving how loss of 6-O-sulfation leads to both elevated FGF8 levels and excessive signaling.","evidence":"Ex vivo neural tissue cultures from Hs6st1−/− embryos challenged with exogenous FGF8, with immunofluorescence for FGF8 gradient and pERK","pmids":["29158323"],"confidence":"High","gaps":["Mechanism by which 6-O-sulfation accelerates FGF8 gradient formation (diffusion vs. degradation vs. receptor turnover) not distinguished","Whether this gradient-shaping function applies to other FGF family members is untested"]},{"year":2018,"claim":"A human HS6ST1 missense mutation causing reduced enzymatic activity was linked to familial delayed puberty, extending the gene's role from brain morphogenesis to neuroendocrine control of puberty onset.","evidence":"In vitro sulfotransferase assay of mutant protein; Hs6st1+/− mouse phenotyping for vaginal opening timing and GnRH neuron counts","pmids":["29931354"],"confidence":"High","gaps":["Downstream signaling pathway mediating puberty delay (FGF vs. other HS-dependent ligands) not identified","Whether haploinsufficiency affects GnRH neuron migration, axon targeting, or secretory function is unknown"]},{"year":2023,"claim":"Gain- and loss-of-function experiments in Xenopus showed that HS6ST1 differentially sorts morphogens—retaining FGF8 locally while dispersing Noggin—demonstrating a conserved morphogen-selective gradient mechanism in neuroectodermal patterning.","evidence":"mRNA overexpression and CRISPR/Cas9 knockout in Xenopus with immunostaining for Fgf8a and Noggin distribution","pmids":["36739958"],"confidence":"Medium","gaps":["Biochemical basis for differential retention of FGF8 vs. dispersal of Noggin by 6-O-sulfated HS not defined","Contribution of other sulfotransferases to this selectivity not assessed"]},{"year":null,"claim":"Key unresolved questions include the structural basis for HS6ST1 substrate selectivity, the identity of specific HS proteoglycan carriers mediating its developmental effects, and whether its roles in FGF gradient regulation and TGF-β1 signaling share a common sulfation-dependent mechanism.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure of HS6ST1 with bound substrate","Specific HSPG carriers (e.g., syndecan, glypican) mediating HS6ST1's effects in vivo are unidentified","Whether FGF8 gradient regulation and TGF-β1 pathway support involve the same sulfated HS epitopes is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,4]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,3,4]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,2,3,4]}],"complexes":[],"partners":["FGF8","FGFR1"],"other_free_text":[]},"mechanistic_narrative":"HS6ST1 is a heparan sulfate 6-O-sulfotransferase that modulates extracellular morphogen gradients and downstream signaling to regulate developmental patterning and neuroendocrine function. By catalyzing 6-O-sulfation of heparan sulfate chains, HS6ST1 shapes FGF8 protein distribution and restrains FGF8/ERK signaling intensity in the developing telencephalic midline; loss of this activity causes corpus callosum agenesis through precocious glial accumulation and ERK hyperactivation, a phenotype rescued by genetic or pharmacological suppression of the FGF8/ERK axis [PMID:24501377, PMID:29158323]. In Xenopus neuroectoderm, HS6ST1-mediated sulfation differentially retains Fgf8a on expressing cells while dispersing the BMP antagonist Noggin, thereby patterning the neural plate [PMID:36739958]. A loss-of-function missense mutation in HS6ST1 causes familial delayed puberty in humans, and heterozygous loss in mice delays pubertal onset without reducing GnRH neuron number, establishing HS6ST1 as a regulator of puberty timing [PMID:29931354]."},"prefetch_data":{"uniprot":{"accession":"O60243","full_name":"Heparan-sulfate 6-O-sulfotransferase 1","aliases":[],"length_aa":411,"mass_kda":48.2,"function":"6-O-sulfation enzyme which catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan sulfate. Critical for normal neuronal development where it may play a role in neuron branching. May also play a role in limb development. May prefer iduronic acid","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/O60243/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/HS6ST1","classification":"Common Essential","n_dependent_lines":629,"n_total_lines":1208,"dependency_fraction":0.5206953642384106},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HS6ST1","total_profiled":1310},"omim":[{"mim_id":"615271","title":"HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21","url":"https://www.omim.org/entry/615271"},{"mim_id":"615270","title":"HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20","url":"https://www.omim.org/entry/615270"},{"mim_id":"614880","title":"HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15","url":"https://www.omim.org/entry/614880"},{"mim_id":"614838","title":"HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9","url":"https://www.omim.org/entry/614838"},{"mim_id":"608137","title":"NMDA RECEPTOR SYNAPTONUCLEAR SIGNALING AND NEURONAL MIGRATION FACTOR; NSMF","url":"https://www.omim.org/entry/608137"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HS6ST1"},"hgnc":{"alias_symbol":[],"prev_symbol":["HS6ST"]},"alphafold":{"accession":"O60243","domains":[{"cath_id":"3.40.50","chopping":"71-368","consensus_level":"high","plddt":94.6063,"start":71,"end":368}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60243","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60243-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60243-F1-predicted_aligned_error_v6.png","plddt_mean":86.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HS6ST1","jax_strain_url":"https://www.jax.org/strain/search?query=HS6ST1"},"sequence":{"accession":"O60243","fasta_url":"https://rest.uniprot.org/uniprotkb/O60243.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60243/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60243"}},"corpus_meta":[{"pmid":"29931354","id":"PMC_29931354","title":"HS6ST1 Insufficiency Causes Self-Limited Delayed Puberty in Contrast With Other GnRH Deficiency Genes.","date":"2018","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29931354","citation_count":33,"is_preprint":false},{"pmid":"29104277","id":"PMC_29104277","title":"Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29104277","citation_count":31,"is_preprint":false},{"pmid":"24501377","id":"PMC_24501377","title":"Heparan sulfotransferases Hs6st1 and Hs2st keep Erk in check for mouse corpus callosum development.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24501377","citation_count":26,"is_preprint":false},{"pmid":"23074159","id":"PMC_23074159","title":"Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development.","date":"2012","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23074159","citation_count":16,"is_preprint":false},{"pmid":"29158323","id":"PMC_29158323","title":"FGF8 morphogen gradients are differentially regulated by heparan sulphotransferases Hs2st and Hs6st1 in the developing brain.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/29158323","citation_count":13,"is_preprint":false},{"pmid":"35899427","id":"PMC_35899427","title":"Convergent biological pathways underlying the Kallmann syndrome-linked genes Hs6st1 and Fgfr1.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35899427","citation_count":9,"is_preprint":false},{"pmid":"36739958","id":"PMC_36739958","title":"The heparan sulfate modification enzyme, Hs6st1, governs Xenopus neuroectodermal patterning by regulating distributions of Fgf and Noggin.","date":"2023","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36739958","citation_count":4,"is_preprint":false},{"pmid":"36586771","id":"PMC_36586771","title":"HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression.","date":"2022","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/36586771","citation_count":2,"is_preprint":false},{"pmid":"40724652","id":"PMC_40724652","title":"Spontaneous Improvement of Hypogonadotropic Hypogonadism in a Patient with PCSK1 and HS6ST1 Mutations: A Case Report.","date":"2025","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/40724652","citation_count":0,"is_preprint":false},{"pmid":"41727567","id":"PMC_41727567","title":"HS6ST1 regulates acute myeloid leukemia chemotherapy resistance via TGF-β1 signaling.","date":"2026","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/41727567","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6974,"output_tokens":2098,"usd":0.026196},"stage2":{"model":"claude-opus-4-6","input_tokens":5373,"output_tokens":1838,"usd":0.109223},"total_usd":0.135419,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"A missense mutation in HS6ST1 identified in a familial delayed puberty pedigree reduces heparan sulfate 6-O-sulfotransferase enzymatic activity in vitro, and heterozygous Hs6st1 loss in mice causes delayed vaginal opening (a proxy for delayed puberty) without affecting GnRH neuron counts.\",\n      \"method\": \"In vitro sulfotransferase activity assay of mutant protein; Hs6st1+/- mouse phenotyping (vaginal opening timing, GnRH neuron immunostaining)\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro enzymatic assay of mutant plus in vivo mouse loss-of-function with defined phenotypic readout\",\n      \"pmids\": [\"29931354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Hs6st1 loss-of-function in mice causes corpus callosum agenesis associated with precocious accumulation of Sox9+ glial cells at the indusium griseum, hyperactivation of ERK signaling (~6-fold) in the telencephalic midline, and elevated Fgf8 protein levels (~2-fold); genetic or pharmacological suppression of the Fgf8/ERK axis rescues both the glial and axonal CC phenotypes, placing Hs6st1 upstream of Fgf8/ERK in corpus callosum development.\",\n      \"method\": \"Hs6st1-/- mouse genetics, immunohistochemistry for Sox9 and pERK, Western blotting for Fgf8, genetic rescue (Fgf8 hypomorph crosses), pharmacological ERK inhibition\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, multiple orthogonal methods, genetic and pharmacological epistasis rescue\",\n      \"pmids\": [\"24501377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In ex vivo mouse neural tissue lacking Hs6st1, exogenous Fgf8 protein gradient formation is delayed and the steady-state Fgf8 protein levels in the gradient are significantly elevated compared to wild type; additionally, Hs6st1-deficient tissue shows enhanced ERK signaling in response to Fgf8, demonstrating that Hs6st1 normally acts as an agonist of Fgf8-induced ERK signaling and stabilizes Fgf8 concentration gradients.\",\n      \"method\": \"Ex vivo living neural tissue cultures from Hs6st1-/- embryos challenged with exogenous Fgf8; immunofluorescence for Fgf8 protein gradient and pERK; heparanase enzymatic removal controls\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct ex vivo assay in KO tissue with multiple orthogonal readouts (gradient imaging, ERK signaling), physiological relevance confirmed in vivo\",\n      \"pmids\": [\"29158323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hs6st1 is expressed at the tips of elongating prostatic epithelial buds (where Sulf1 is excluded), creating a zone of high HS 6-O sulfation at bud tips that supports FGF10-mediated ERK1/2 signaling; this spatial regulation opposes the Sulf1-mediated reduction of 6-O sulfation in peri-mesenchymal epithelium that is induced by BMP signaling.\",\n      \"method\": \"In situ hybridization for Hs6st1/Sulf1 expression, immunohistochemistry for 6-O sulfated HS, exogenous BMP4/BMP7 treatment with ERK1/2 readout in urogenital sinus explants\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — expression-based localization plus functional IHC and BMP treatment assay; single lab, moderate mechanistic depth\",\n      \"pmids\": [\"23074159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In Xenopus, Hs6st1 is expressed in the lateral sensorial layer of neuroectoderm and its activity causes cell-autonomous retention of Fgf8a on Hs6st1-expressing cells while promoting dispersal of the BMP antagonist Noggin away from those cells; Hs6st1 overexpression expands the neural plate (Sox3+) domain, and CRISPR/Cas9 knockout expands the neural plate and causes retinal malformation, demonstrating that Hs6st1-mediated 6-O sulfation differentially regulates morphogen distributions to pattern the neuroectoderm.\",\n      \"method\": \"In situ hybridization, Hs6st1 mRNA overexpression, CRISPR/Cas9 knockout in Xenopus, immunostaining for Fgf8a and Noggin distribution\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with morphogen localization readouts in Xenopus ortholog; single lab\",\n      \"pmids\": [\"36739958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Disruption of Hs6st1 in mouse neuronal cells (and parallel disruption of Fgfr1) alters transcriptome in convergent biological processes: upregulation of extracellular pathway genes and downregulation of chromatin pathway genes; bioinformatics analysis indicates Hs6st1 and Fgfr1 regulate gene transcription via the transcription factors Sox9/Sox10 and chromatin regulator Chd7.\",\n      \"method\": \"RNA sequencing of Hs6st1-disrupted mouse neuronal cells, machine learning-based mutation effect prediction, genomics/bioinformatics pathway analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 — transcriptomics and bioinformatics without direct protein-level mechanistic validation\",\n      \"pmids\": [\"35899427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"HS6ST1 depletion in AML cells increases sensitivity to cytarabine and reduces TGF-β1-mediated pro-survival signaling, demonstrating that HS6ST1 promotes chemotherapy resistance by supporting TGF-β1 signaling; HS2ST1 depletion (but not HS6ST1 depletion) increases bone marrow leukemic burden in cell-line-derived xenografts.\",\n      \"method\": \"shRNA/CRISPR depletion of HS6ST1 in AML cell lines, cytarabine sensitivity assays, TGF-β1 signaling readouts, cell-line-derived xenograft models, surfen (HS antagonist) combination treatment\",\n      \"journal\": \"Research square\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined signaling pathway (TGF-β1) and phenotypic readout (drug resistance), in vitro and in vivo; single lab, preprint\",\n      \"pmids\": [\"41727567\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"HS6ST1 is a heparan sulfate 6-O-sulfotransferase that catalyzes sulfation of heparan sulfate chains to modulate extracellular morphogen (particularly FGF8) gradients and downstream ERK signaling, thereby regulating brain midline/corpus callosum development, puberty onset via GnRH neuron function, neuroectodermal patterning, and AML chemotherapy resistance through TGF-β1 pathway support.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HS6ST1 is a heparan sulfate 6-O-sulfotransferase that modulates extracellular morphogen gradients and downstream signaling to regulate developmental patterning and neuroendocrine function. By catalyzing 6-O-sulfation of heparan sulfate chains, HS6ST1 shapes FGF8 protein distribution and restrains FGF8/ERK signaling intensity in the developing telencephalic midline; loss of this activity causes corpus callosum agenesis through precocious glial accumulation and ERK hyperactivation, a phenotype rescued by genetic or pharmacological suppression of the FGF8/ERK axis [PMID:24501377, PMID:29158323]. In Xenopus neuroectoderm, HS6ST1-mediated sulfation differentially retains Fgf8a on expressing cells while dispersing the BMP antagonist Noggin, thereby patterning the neural plate [PMID:36739958]. A loss-of-function missense mutation in HS6ST1 causes familial delayed puberty in humans, and heterozygous loss in mice delays pubertal onset without reducing GnRH neuron number, establishing HS6ST1 as a regulator of puberty timing [PMID:29931354].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"HS6ST1 was shown to create spatially restricted zones of high 6-O-sulfation at prostatic epithelial bud tips that support FGF10/ERK signaling, establishing that its sulfotransferase activity has localized signaling consequences in developing tissues.\",\n      \"evidence\": \"In situ hybridization, immunohistochemistry for 6-O-sulfated HS, and BMP treatment of urogenital sinus explants in mouse\",\n      \"pmids\": [\"23074159\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequence of Hs6st1 loss in prostate branching not tested by knockout\",\n        \"Relationship between 6-O-sulfation and FGF10 binding affinity not biochemically resolved\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Hs6st1 knockout in mice revealed that 6-O-sulfation acts upstream of FGF8/ERK signaling in corpus callosum formation, with loss causing glial fate precocity and axon guidance failure—both rescued by reducing FGF8 or ERK activity.\",\n      \"evidence\": \"Hs6st1−/− mouse analysis with immunohistochemistry, Western blotting, genetic crosses to Fgf8 hypomorphs, and pharmacological ERK inhibition\",\n      \"pmids\": [\"24501377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether HS6ST1 directly modifies HS chains that bind FGF8 or acts through intermediate proteoglycans is unresolved\",\n        \"Cell-type-specific contributions (glia vs. neurons) not dissected with conditional knockouts\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Ex vivo gradient assays demonstrated that Hs6st1 directly shapes extracellular FGF8 protein gradients and normally restrains ERK hyperactivation, resolving how loss of 6-O-sulfation leads to both elevated FGF8 levels and excessive signaling.\",\n      \"evidence\": \"Ex vivo neural tissue cultures from Hs6st1−/− embryos challenged with exogenous FGF8, with immunofluorescence for FGF8 gradient and pERK\",\n      \"pmids\": [\"29158323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which 6-O-sulfation accelerates FGF8 gradient formation (diffusion vs. degradation vs. receptor turnover) not distinguished\",\n        \"Whether this gradient-shaping function applies to other FGF family members is untested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A human HS6ST1 missense mutation causing reduced enzymatic activity was linked to familial delayed puberty, extending the gene's role from brain morphogenesis to neuroendocrine control of puberty onset.\",\n      \"evidence\": \"In vitro sulfotransferase assay of mutant protein; Hs6st1+/− mouse phenotyping for vaginal opening timing and GnRH neuron counts\",\n      \"pmids\": [\"29931354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream signaling pathway mediating puberty delay (FGF vs. other HS-dependent ligands) not identified\",\n        \"Whether haploinsufficiency affects GnRH neuron migration, axon targeting, or secretory function is unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Gain- and loss-of-function experiments in Xenopus showed that HS6ST1 differentially sorts morphogens—retaining FGF8 locally while dispersing Noggin—demonstrating a conserved morphogen-selective gradient mechanism in neuroectodermal patterning.\",\n      \"evidence\": \"mRNA overexpression and CRISPR/Cas9 knockout in Xenopus with immunostaining for Fgf8a and Noggin distribution\",\n      \"pmids\": [\"36739958\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Biochemical basis for differential retention of FGF8 vs. dispersal of Noggin by 6-O-sulfated HS not defined\",\n        \"Contribution of other sulfotransferases to this selectivity not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for HS6ST1 substrate selectivity, the identity of specific HS proteoglycan carriers mediating its developmental effects, and whether its roles in FGF gradient regulation and TGF-β1 signaling share a common sulfation-dependent mechanism.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No crystal structure of HS6ST1 with bound substrate\",\n        \"Specific HSPG carriers (e.g., syndecan, glypican) mediating HS6ST1's effects in vivo are unidentified\",\n        \"Whether FGF8 gradient regulation and TGF-β1 pathway support involve the same sulfated HS epitopes is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 3, 4]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FGF8\",\n      \"FGFR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}